A novel imaging approach, 68Ga-pentixafor PET/CT, has been shown to accurately identify sub-types of primary aldosteronism (an adrenal gland disorder), outperforming traditional methods for diagnosis.
Bristol Myers and 2seventy bio say FDA delayed CAR-T therapy decision
The FDA is delaying its decision on whether to approve Bristol Myers Squibb and 2seventy bio’s CAR-T cell therapy for multiple myeloma in earlier lines
November 21, 2023